DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09

Found vs IVIM Health vs Lavender Sky Health (2026)

On tirzepatide, the order is IVIM Health ($278) → Found ($289) → Lavender Sky Health ($352) — gaps of $11 and then $63 a month, a $888 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

The three records, one screen

IVIM Health: the record, condensed

On tirzepatide, the number that matters at IVIM Health is $278 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Note the shape: $208 is the number in the marketing, $278 is the number at maintenance. The $70 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

A required $75/month membership is part of the deal, and part of the figure above: $203 of medication plus $75 of platform equals the $278 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #3 of 17 verified programs, with the floor $63/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.

On semaglutide, the number that matters at IVIM Health is $149 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

The all-in figure already contains a compulsory $75 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $74 would be exactly that kind of mirage.

Context for that figure: it ranks #3 of 20 in the verified semaglutide index — $16/month above the floor (Oak Longevity, $133) — and sits $200 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $1,788.

Operationally at IVIM Health: shipping included; commitment membership mandatory for duration; cancellation membership mandatory; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the IVIM Health page · visit IVIM Health ↗

Found: the record, condensed

Start with the load-bearing figure: $289 a month, all-in, is what Found charges for tirzepatide at the 10 mg basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Found is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #6 of 17 verified programs, with the floor $74/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $160 a month. A year at this figure: $3,468 monthly-billed.

Start with the load-bearing figure: $289 a month, all-in, is what Found charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $289 is the whole subscription, which makes Found unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #15 of 20 in the verified semaglutide index — $156/month above the floor (Oak Longevity, $133) — and sits $60 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $3,468.

Operationally at Found: shipping included; commitment none month-to-month; prepaid terms for lowest rate; cancellation membership recurs; prepaid terms are paid up front; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Found page · visit Found ↗

Lavender Sky Health: the record, condensed

Start with the load-bearing figure: $352 a month, all-in, is what Lavender Sky Health charges for tirzepatide at the 10 mg basis. Pricing steps with the dose here: from $200 at entry to $352 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $1,824 a year, which is why every ranking on this site uses the larger number.

The all-in figure already contains a compulsory $25 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $327 would be exactly that kind of mirage.

To place the number: #12 of 17 verified programs, with the floor $137/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $97 a month. A year at this figure: $4,224 monthly-billed.

Start with the load-bearing figure: $174 a month, all-in, is what Lavender Sky Health charges for semaglutide at the 2.4 mg basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

Inside that $174 sits a mandatory $25-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $149, and it is not a price anyone can actually pay, because the membership cannot be declined.

Context for that figure: it ranks #6 of 20 in the verified semaglutide index — $41/month above the floor (Oak Longevity, $133) — and sits $175 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,088.

Operationally at Lavender Sky Health: shipping included; commitment monthly plan fee recurs; cancellation plan fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Lavender Sky Health page · visit Lavender Sky Health ↗

Prices, gaps, and what sits inside them

IVIM Health holds the low ground at $278 (its $75 membership already inside). Found follows at $289 (+$11/mo, $132/yr). Lavender Sky Health tops the trio at $352 (+$74/mo over the leader, $888/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles nothing: IVIM Health $149 → Lavender Sky Health $174 → Found $289 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

Who wins what

Cheapest month-to-month: IVIM Health ($278); cheapest 12-month path: IVIM Health ($3,336); simplest billing (no membership): Found; dose-flat structure: Found; cheapest semaglutide of the three: IVIM Health ($149).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: IVIM Health vs Found · IVIM Health vs Lavender Sky Health (record · record) · Found vs Lavender Sky Health (record · record).

Everything besides the three prices

Memberships: IVIM Health $75/mo (inside its figure); Found none; Lavender Sky Health $25/mo (inside its figure). Structures: IVIM Health step/tiered; Found dose-flat; Lavender Sky Health step/tiered. Pharmacies: IVIM Health not named; Found not named; Lavender Sky Health not named. States: IVIM Health — not published; Found — most states; Lavender Sky Health — not published. Exit terms: IVIM Health — membership mandatory; Found — membership recurs; prepaid terms are paid up front; Lavender Sky Health — plan fee recurs until cancelled.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: IVIM Health source-verified (2026-08-05); Found third-party reported (2026-08-05); Lavender Sky Health source-verified (2026-08-05).

The trio on semaglutide, across time

3 mo: IVIM Health $447 vs Lavender Sky Health $522 vs Found $867 6 mo: IVIM Health $894 vs Lavender Sky Health $1,044 vs Found $1,734 12 mo: IVIM Health $1,788 vs Lavender Sky Health $2,088 vs Found $3,468 — monthly-billed totals; prepaid paths where published appear on each provider page.

The trio, annualized

IVIM Health: $3,336/yr monthly-billed; Found: $3,468/yr monthly-billed; Lavender Sky Health: $4,224/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,776 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

A three-way choice is really two eliminations, so run them in order. Eliminate Lavender Sky Health first unless it names its edge: at $352 it carries a $74/month premium over the floor of this trio — $888 a year, about 3.2 extra months of therapy at IVIM Health’s rate — and a premium that size must point at a specific line in its record (the services inside its $25/mo membership) or it is decoration. Then interrogate Found’s middle ground: its dose-flat structure removes titration repricing; if that specific thing is on your personal ledger, the $11/month over the floor can be rational — if not, the middle is where budgets go to leak. What survives is IVIM Health at $278, which wins by default rather than by argument — exactly how a price index should crown things — subject to the two checks no ranking can run for you: your state at intake, and your prescriber on the medication itself.

The same trio on best published rate: IVIM Health $278 → Found $289 → Lavender Sky Health $352 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — IVIM Health $834, Found $867, Lavender Sky Health $1,056; 6 months — IVIM Health $1,668, Found $1,734, Lavender Sky Health $2,112. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

The record-quality read, scored on the five checkable disclosures this index tracks (maintenance price, named pharmacy, published states, published cancellation terms, source-verified capture): IVIM Health 4/5, Found 3/5, Lavender Sky Health 4/5. IVIM Health discloses the most and Found the least, and in this market disclosure predicts disclosure — the axis where a program goes quiet is reliably where its checkout surprises live. The three match on every disclosure axis, which is rare and worth noting in their favor collectively. Scores recompute from the public records like everything else here.

Read as a decision: start from IVIM Health and make the other two argue upward. Found’s case is its structure; Lavender Sky Health’s case must be worth $888 a year in named features — the honest unit being months of medication (3.2 of them at the floor rate). The pairwise pages above hold each argument in full, and the calculator holds your version of it.

Frequently asked

Which is cheapest: Found, IVIM Health, or Lavender Sky Health?

IVIM Health, at $278/month all-in tirzepatide — $11 under Found and $74 under Lavender Sky Health; on semaglutide the cheapest of the three is IVIM Health at $149. Captured 2026-08-09.

Which of the three is best over a full year?

IVIM Health’s best path prices twelve months at $3,336; monthly-billed years run IVIM Health $3,336, Found $3,468, Lavender Sky Health $4,224.

Are these rankings paid or editorial?

Neither — they are sorts of the public dataset on the all-in maintenance basis, regenerated on every data change; the methodology page defines the basis and the JSON lets you recompute every figure here.